sorafenib has been researched along with e 7010 in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (e 7010) | Trials (e 7010) | Recent Studies (post-2010) (e 7010) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 81 | 15 | 41 |
| Protein | Taxonomy | sorafenib (IC50) | e 7010 (IC50) |
|---|---|---|---|
| Tubulin alpha-1A chain | Sus scrofa (pig) | 2.945 | |
| Tubulin beta chain | Sus scrofa (pig) | 2.79 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 2.7 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 2.64 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.7 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.7 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 2.64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Döme, B; Magyar, M | 1 |
2 review(s) available for sorafenib and e 7010
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
[Tumor vasculature as a therapeutic target in non-small cell lung cancer].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Axitinib; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Humans; Imidazoles; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperidines; Pyridines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Sorafenib; Sulfonamides; Xanthones | 2008 |